GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Veritas In Silico Inc (TSE:130A) » Definitions » Market Cap

Veritas In Silico (TSE:130A) Market Cap : 円5,124.8 Mil (As of Dec. 14, 2024)


View and export this data going back to 2024. Start your Free Trial

What is Veritas In Silico Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Veritas In Silico's share price for the quarter that ended in Jun. 2024 was 円1098. Veritas In Silico's Shares Outstanding (EOP) for the quarter that ended in Jun. 2024 was 6.5 Mil. Therefore, Veritas In Silico's market cap for the quarter that ended in Jun. 2024 was 円7,122.8 Mil.

Veritas In Silico's quarterly market cap increased from Dec. 2023 (円0.0 Mil) to Mar. 2024 (円13,065.0 Mil) but then declined from Mar. 2024 (円13,065.0 Mil) to Jun. 2024 (円7,122.8 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Veritas In Silico's Enterprise Value for Today is 円2,868.6 Mil.

Veritas In Silico Market Cap Historical Data

The historical data trend for Veritas In Silico's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Veritas In Silico Market Cap Chart

Veritas In Silico Annual Data
Trend Dec21 Dec22 Dec23
Market Cap
- - -

Veritas In Silico Quarterly Data
Dec21 Dec22 Sep23 Dec23 Mar24 Jun24
Market Cap Get a 7-Day Free Trial - - - 13,065.04 7,122.85

Competitive Comparison of Veritas In Silico's Market Cap

For the Biotechnology subindustry, Veritas In Silico's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Veritas In Silico's Market Cap Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Veritas In Silico's Market Cap distribution charts can be found below:

* The bar in red indicates where Veritas In Silico's Market Cap falls into.


Veritas In Silico Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Veritas In Silico's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )=Share Price (A: Dec. 2023 )*Shares Outstanding (EOP) (A: Dec. 2023 )
=円0*6.30131
=円0.0

Veritas In Silico's Market Cap for the quarter that ended in Jun. 2024 is calculated as

Market Cap (Q: Jun. 2024 )=Share Price (Q: Jun. 2024 )*Shares Outstanding (EOP) (Q: Jun. 2024 )
=円1098*6.48711
=円7,122.8

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Veritas In Silico  (TSE:130A) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

Veritas In Silico Market Cap Related Terms

Thank you for viewing the detailed overview of Veritas In Silico's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.

Veritas In Silico Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Veritas In Silico Inc (TSE:130A) » Definitions » Market Cap
Comparable Companies
Traded in Other Exchanges
N/A
Address
1-11-1, Nishigotanda, Shinagawa-ku, Tokyo, JPN, 141-0031
Website
https://www.veritasinsilico.com
Veritas In Silico Inc is engaged in discovery of mRNA-targeted small molecule and antisense oligonucleotide drugs. It has ibVIS platform that combines informatics (i) and experimental biology at Veritas In Silico (VIS) that will bring to fruition mRNA-targeted drugs.

Veritas In Silico Headlines

No Headlines